A Crisis of Patent Law and Medical Innovation: The Category of Diagnostic Claims in the Wake of Arioso v. Sequenom.

The article analysis the scope of patent eligibility of diagnostic tests in the U.S. focusing on Ariosa v. Sequenom and Mayo Collaborative Servs. v. Prometheus Labs., Inc. court case. Topics discussed include issues of patent law and medical innovation; analysis of Ariosa v. Sequenom and its implications for decisions on the patent eligibility of diagnostic tests; and analysis of current patent subject-matter eligibility test by the U.S. Patent and Trademark Office.